Top Markets
Coin of the day
IRRAS AB (publ) IRRAS AB (publ)

IRRAS AB (publ)

IRRAS
Rank in Stocks #29628
IRRAS AB (publ), a medical technology company established in 2011 and... IRRAS AB (publ), a medical technology company established in 2011 and headquartered in Stockholm, Sweden, is dedicated to developing medical solutions that enhance the lives of critically ill patients globally. The firm specializes in neurocritical care products, aiming to transform patient outcomes and address complexities inherent in current treatment methods. Among its offerings is IRRAflow, an advanced irrigating intracranial drainage system that integrates controlled drainage, automated irrigation, and continuous intracranial pressure (ICP) monitoring, used effectively for treating hemorrhagic strokes and chronic subdural hematoma. Additionally, IRRAS provides the Hummingbird ICP monitoring system, comprising the HICP200 Control Module and various catheters like the H610 for quad ICP monitoring with drainage and the H110 for solo ICP monitoring. These Hummingbird neuromonitoring tools are vital for managing patients with elevated ICP caused by conditions such as traumatic brain injury, subarachnoid hemorrhage, and strokes. The company distributes its products to hospitals through both its direct sales force and a network of strategic distribution partners.
Share Price
$0.01791564
Last synced: 2023-11-03
Market Cap
$20.30M
Change (1 day)
22.81%
Change (1 year)
0.00%
Country
SE
Trade IRRAS AB (publ) (IRRAS)

Category

EPS for IRRAS AB (publ) (IRRAS)
EPS as of 2026 TTM: 0
According to IRRAS AB (publ) latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for IRRAS AB (publ) from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
$3.11 -
US
$9.73 -
US
$3.59 -
IE
$2.48 -
US
- -
DE